Psoriasis Newswire (Page 2)

Psoriasis Newswire (Page 2)

Comprehensive Real-Time News Feed for Psoriasis. (Page 2)

Results 21 - 40 of 823 in Psoriasis

  1. Coherus BioSciences Inc. (CHRS) Downgraded by Zacks Investment ResearchRead the original story w/Photo

    Monday Aug 15 | AmericanBankingNews.com

    According to Zacks, "Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients.

    Comment?

  2. Coherus BioSciences Inc. (CHRS) Downgraded by Zacks Investment Research to SellRead the original story w/Photo

    Monday Aug 15 | AmericanBankingNews.com

    According to Zacks, "Coherus Biosciences, Inc. is a biologics platform company developing biosimilar therapeutics. Its clinical stage pipeline consists of CHS-0214 in two Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis; CHS-1420 that has completed a Phase I study to treat psoriasis or rheumatoid arthritis; and CHS-1701 which has completed a Phase I study for the treatment of breast cancer patients.

    Comment?

  3. What People With Psoriasis Want You to KnowRead the original story w/Photo

    Monday Aug 15 | WebMD

    Even if you don't know someone with psoriasis , you may have seen a person with signs of the disease. The red, scaly skin patches, small red dots, or pus-filled blisters can show up where it's hard to hide them -- the elbows, the hands, even the face.

    Comment?

  4. What is psorasis? Top tips to help soothe the painful skin conditionRead the original story w/Photo

    Saturday Aug 13 | Mirror.co.uk

    There are 1.8 million people living with psoriasis in the UK. The scaly, red, itchy patches of skin can be hugely troublesome for some.

    Comment?

  5. Research supports targeting enzyme group to treat autoimmune diseasesRead the original story w/Photo

    Friday Aug 12 | PhysOrg Weblog

    New research from the University of Dundee, and funded by Arthritis Research UK and the MRC, has shown that targeting a specific group of enzymes could be a viable strategy for treating autoimmune diseases such as psoriasis and multiple sclerosis, which affect millions of people. Autoimmune diseases develop when the immune system, which defends the body against disease, is convinced that our healthy cells are foreign.

    Comment?

  6. Valeant Maintains 2016 Forecast Despite Sales, Earnings MissRead the original story w/Photo

    Tuesday Aug 9 | Bloomberg

    ... obligations. Valeant also announced the divestiture or agreement to sell assets such as the European rights to psoriasis drug brodalumab; the U.S. equipment manufacturing arm of Synergetics, part of eye-care company Bausch & Lomb; and drug Ruconest. ...

    Comment?

  7. O U...O O U O O Uoeo OaO U O O1U URead the original story w/Photo

    Saturday Aug 6 | Al Bawaba

    In recognition of Psoriasis Awareness Month, observed each August, Hamad Medical Corporation is raising awareness about the misunderstood skin disease. "Psoriasis is a persistent, chronic, systemic disease of the immune system which can be hereditary.

    Comment?

  8. Psoriasis not contagious: HMC doctorRead the original story w/Photo

    Saturday Aug 6 | The Peninsula

    Doha: In recognition of Psoriasis Awareness Month observed in August, Hamad Medical Corporation is raising awareness about the misunderstood skin disease. "Psoriasis is a persistent, chronic, systemic disease of the immune system which can be hereditary.

    Comment?

  9. 8 things to know about Tiara Pennington, Miss Alabama's Outstanding Teen 2016Read the original story w/Photo

    Saturday Aug 6 | Alabama Live

    ... named one of six finalists for the Teens in Action Award that came with a $1,000 scholarship. She's the founder of Psoriasis Take Action Alabama. She started the group to provide more resources to people in the state with psoriasis and psoriatic ...

    Comment?

  10. Express Scripts releases list of costly drugs it won't cover for 2017 ...Read the original story w/Photo

    Tuesday Aug 2 | Business Insurance

    Express Scripts Holding Co. said on Monday it would add a handful of medicines in 2017 to its list of drugs that are excluded from insurance coverage, including treatments for arthritis and psoriasis, while several other medicines will be removed from the exclusion list.

    Comment?

  11. Express Scripts Says Valeant, Lilly, Bristol Drugs to Lack CoverageRead the original story w/Photo

    Tuesday Aug 2 | Fox News

    Express Scripts Holding said on Monday it would add a handful of medicines in 2017 to its list of drugs that are excluded from insurance coverage, including treatments for arthritis and psoriasis, while several other medicines will be removed from the exclusion list. The nation's largest pharmacy benefit manager has been excluding medicines from its coverage list since 2014, citing concern about costs to its health insurers and corporate customers.

    Comment?

  12. Express Scripts says Valeant, Lilly, Bristol drugs to lack coverageRead the original story w/Photo

    Monday Aug 1 | Reuters

    Express Scripts Holding Co said on Monday it would add a handful of medicines in 2017 to its list of drugs that are excluded from insurance coverage, including treatments for arthritis and psoriasis, while several other medicines will be removed from the exclusion list. The nation's largest pharmacy benefit manager has been excluding medicines from its coverage list since 2014, citing concern about costs to its health insurers and corporate customers.

    Comment?

  13. BRIEF-Express Scripts adds Lilly's Taltz psoriasis drug to its excluded medicines listRead the original story

    Monday Aug 1 | Reuters

    Aug 1 Express Scripts : * says adds Eli Lilly's new Taltz psoriasis drug to its list of excluded medications, making it ineligible for coverage.

    Comment?

  14. Treating Psoriasis May Reduce Risk for Other IllsRead the original story w/Photo

    Jul 29, 2016 | WebMD

    About 7.5 million people in the United States have the chronic skin disease. The inflammatory effects of psoriasis can affect the entire body, said Dr. Jashin Wu, director of dermatology research at Kaiser Permanente Los Angeles Medical Center.

    Comment?

  15. Lilly's Growth Prospects Are ImprovingRead the original story

    Monday Aug 1 | Morningstar

    ... revenue growth over the same period. On the pipeline side, we expect over $1 billion in peak annual sales from psoriasis drug Taltz and rheumatoid arthritis drug baricitinib. Also, strong cardiovascular data for Lilly's diabetes drug Jardiance ...

    Comment?

  16. Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2Read the original story w/Photo

    Jul 28, 2016 | BioMed Central

    Psoriasis is a chronically recurrent inflammatory skin disease, modern medicine could achieve good therapeutic effect, but these treatments led to recurrence of the psoriasis, more severe symptoms due to damaging skin barrier. Traditional Chinese medicine is a useful alternative therapies.

    Comment?

  17. Dermatology Specialists opens Clearwater officeRead the original story w/Photo

    Jul 28, 2016 | Tampa Bay Newspapers

    ... and has served as past president of the Pinellas County Osteopathic Medical Society and served on the National Psoriasis Foundation West Coast Florida Division. Armstrong has extensive experience in the diagnosis of benign and malignant growths, ...

    Comment?

  18. Celgene's Otezla Is A Big HitRead the original story w/Photo

    Jul 28, 2016 | The Motley Fool

    Second quarter sales of Otezla clocked in at $242 million, up 170% from last year and 24% from Q1. Can Otezla's sales continue to head higher? Psoriasis affects 125 million people worldwide and that makes it a major indication responsible for generating billions of dollars in sales for top drugmakers.

    Comment?

  19. Chad Mendes Blames Failed USADA Drug Test on Psoriasis Treatment CreamRead the original story w/Photo

    Jul 28, 2016 | Sherdog

    ... Mendes does not deny taking the substance, but he claims that it was from a skin cream used to treat plaque psoriasis, a condition the fighter says he's dealt with his entire life. The former featherweight title challenger addressed the situation ...

    Comment?

  20. Treating psoriasis may improve related cardiovascular symptomsRead the original story

    Jul 28, 2016 | PressReleasePoint

    Approximately 7.5 million people in the United States have psoriasis, and the impact of this disease goes far beyond its visible effects on the skin. People with psoriasis, particularly those with more severe disease, have an increased risk for a variety of other health problems, including obesity, diabetes, high blood pressure, high cholesterol, stroke and heart attack, " says board-certified dermatologist Jashin J. Wu, MD, FAAD, director of dermatology research at the Kaiser Permanente Los Angeles Medical Center.

    Comment?